A Japan-based phase I trial of forigerimod.

Trial Profile

A Japan-based phase I trial of forigerimod.

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 03 Nov 2011

At a glance

  • Drugs Forigerimod (Primary)
  • Indications Systemic lupus erythematosus
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 03 Nov 2011 Status changed from planning to not yet recruiting.
    • 16 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top